FILE:HUM/HUM-8K-20121105131619.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
 
 
          Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
 
          Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
 
          Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
 
          Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
 
 
Explanatory Note
 
This Current Report on Form 8-K/A is filed as an amendment to the Current Report on Form 8-K filed by Humana Inc. (the Company) on November 5, 2012 (the Original 8-K) to update certain guidance points reported incorrectly in Exhibit 99 to the Original 8-K.  All other disclosures of the Original 8-K remain unchanged.
 
Item 7.01   Regulation FD Disclosure.
 
An earnings release was issued by Humana Inc. this morning reporting financial results for the period ended September 30, 2012, updated 2012 earnings guidance, and financial projections for 2013.  In the financial projections for 2013, due to a scriveners error, certain guidance points were reported
inaccurately.  The following corrects and replaces certain 2013 guidance points for the Health and Well-Being Services Segment included in the Original 8-K:
 
 
 
 
 
 
 
 
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
                  
 
 
 
Dated:    November 5, 2012


